Scientists have identified a previously unknown biological mechanism through which high-cholesterol diets impair the body's natural cholesterol-regulating defenses, according to research that could reshape future treatment approaches. The study found that blocking this pathway dramatically lowered harmful LDL cholesterol in mice, offering a potential new target for intervention. Researchers say the discovery helps explain why dietary cholesterol can overwhelm the body's own safeguards, a question that has long puzzled specialists in cardiovascular health.
In a notable development, an experimental drug designed to target this pathway has already cleared an early-stage human safety trial, a step that could accelerate the timeline toward a new therapy for high cholesterol. While the findings remain preliminary and larger human trials are needed to confirm efficacy, the combination of animal results and early safety data has drawn interest from researchers seeking alternatives for patients who cannot tolerate existing statin treatments. Further studies are expected to clarify the mechanism's role in human cholesterol regulation.
Independent reporting synthesized from primary wires and global correspondents.